Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial

Affiliations

• ¹ Hematology, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Obstetrics and Gynecology, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada. Electronic address: mrodger@ohri.ca.
• ² Hematology, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
• ³ Department of Medicine, McGill University, Canada; Department of Obstetrics & Gynecology, McGill University, Canada.
• ⁴ McMaster University, Hamilton, Ontario, Canada.
• ⁵ University of Alberta, Edmonton, Alberta, Canada.
• ⁶ Department of Obstetrics and Gynecology, University of Virginia, United States.
• ⁷ Division of Hematology, University of Washington, United States; Puget Sound Blood Center, United States.